TWIST1 and breast carcinoma: Consistent with this finding, enhanced expression of TWIST protein and mRNA expression has been reported in patients diagnosed with invasive ductal carcinomas with shorter progression-free survival [46]; TWIST-mediated EMT in breast cancer cells have been shown to predict poor prognosis in breast cancer patients [47]; promote invasion, metastasis and therapeutic resistance through cancer stem cell phenotype [48].